"... pioneering research is underway to repurpose low-cost, off-patent medications such as beta-blockers to treat cancer.
The [Gillies McIndoe Research Institute] executive director Dr Swee Tan said a phase I clinical trial showed the drugs extended the life expectancy for glioblastoma brain cancer by five-and-a half months with minimal side effects."
#RachelThomas, 2023